Hepatitis C in renal transplant recipients – Safety and efficacy of a conversion of immunosuppression to high-dose cyclosporine A and its impact on HCV-replication, parameters of liver function and glucose tolerance. An open label trial.
Phase of Trial: Phase IV
Latest Information Update: 12 Oct 2012
At a glance
- Drugs Ciclosporin (Primary)
- Indications Renal transplant rejection
- Focus Pharmacodynamics
- 12 Oct 2012 New trial record